Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > -43% down YTD

<< Previous

Bullboard Posts

Next >>

Comment by Dumbeldorfwhiteon Nov 18, 2023 7:44am

201 Views

Post# 35742407

RE:RE:RE:RE:-43% down YTD

Just speculating but maybe sueing shareholders isn't a great idea especially when consistently trying to raise cash, my guess is that goldn1 and skier were probably named and they had large positions according to them. Otherwise how much money was actually recouped in the last suit vs. how much it cost and if that money was that money coming out of TLTs piggy bank?

<< Previous

Bullboard Posts

Next >>

Coppernico in Peru: Inaugural drilling on a promising opportunity